Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GDA | Q9Y2T3 | 3/20 | 0.53 |
| ▸ | PNP | P00491 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 3/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | BLM | P54132 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.35 |
| ▸ | PDE4A | P27815 | 1/20 | 0.35 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.35 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.35 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4560085 | 1.00 | GDA (0.53) | GDAPNPMEN1KMT2APMP22 | |
| 7-Methylxanthine SCHEMBL2466924 | 0.87 | GDA (0.77) | GDAPNPMEN1KMT2APMP22 | |
| Caffeine SCHEMBL1044373 | 0.82 | ADORA2B (0.64) | GDAPMP22CYP3A4MAPK1BLM | |
| SCHEMBL15290224 | 0.81 | ALDH1A1 (0.56) | GDAPNPMEN1KMT2APMP22 | |
| SCHEMBL4379221 | 0.81 | KMT2A (0.45) | GDAPNPMEN1KMT2APMP22 | |
| SCHEMBL2352519 | 0.80 | PNP (0.43) | GDAPNPMEN1KMT2APMP22 | |
| Theophylline Anhydrous SCHEMBL8524559 | 0.79 | ATAD2 (0.62) | CYP3A4MAPK1LMNAMAPTTSHR | |
| SCHEMBL5054173 | 0.78 | PNP (0.54) | GDAPNPMEN1KMT2AALDH1A1 | |
| SCHEMBL618978 | 0.77 | PNP (0.44) | GDAPNPMEN1KMT2APMP22 | |
| SCHEMBL133948 | 0.77 | PNP (0.41) | GDAPNPMEN1KMT2APMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 16045 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747263-A1 | LIPID NANOPARTICLES AND USES THEREOF | University of Connecticut (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4363043-B1 | COMPOSITIONS FOR USE IN METHODS FOR INCREASING CANCER CELL SENSITIVITY TO ALTERNATING ELECTRIC FIELDS | NOVOCURE GMBH (CH) | 2026-04-22 | — | — | EP | claimed |
| EP-4728052-A1 | SYSTEMS AND METHODS OF CELL TRANSPORT AT AMBIENT TEMPERATURE | Bedford Research Foundation (US) | 2026-04-22 | — | — | EP | claimed |
| EP-4719373-A1 | PHOTODYNAMIC THERAPY COMBINATIONS FOR IMPROVEMENT OF ACTINIC KERATOSIS, ACNE AND BASAL CELL CARCINOMA | Alexandroff, Anton (GB) | 2026-04-08 | — | — | EP | claimed |
| US-12594421-B2 | Compositions and methods for increasing cancer cell sensitivity to alternating electric fields | NOVOCURE GMBH (CH) | 2026-04-07 | — | — | US | claimed |
| EP-3521419-B1 | METHOD FOR PRODUCING BROWN ADIPOCYTES AND COMPOSITION | KYOTO PREFECTURAL PUBLIC UNIV CORP (JP) | 2026-03-18 | — | — | EP | claimed |
| US-20260062414-A1 | NOVEL COCRYSTALS OF METHYLXANTHINES, THEIR POLYMORPHS AND PROCESS THEREOF | FERTIS INDIA PVT LTD (IN) | 2026-03-05 | — | — | US | claimed |
| US-20260060970-A1 | Use of a Therapeutic Agent with Phosphodiesterase-7 Inhibitory Activity for the Treatment and Prevention of Diseases Associated with Chronic Fatigue, Exhaustion and/or Exertional Intolerance | MITODICURE GMBH (DE) | 2026-03-05 | — | — | US | claimed |
| US-20260060949-A1 | METHOD FOR TREATING DAMAGE INDUCED BY SLEEP DEPRIVATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2026-03-05 | — | — | US | claimed |
| EP-4696298-A2 | PERSONAL CLEANSING COMPOSITION | Byrne, Daniel (IE) | 2026-02-18 | — | — | EP | claimed |
| US-4753945-A | Stimulation of tear secretion with phosphodiesterase inhibitors | EYE RESEARCH INSTITUTE OF RETINA FOUNDATION (US) | 1988-06-28 | — | — | US | claimed |
| EP-0240511-A1 | AEROSOL | BIOCOMPATIBLES LTD. (GB) | 1987-10-14 | — | — | EP | claimed |
| EP-0234854-A2 | Use of phosphodiesterase inhibitors and cyclic nucleotide analogues for the manufacture of a medicament for stimulating tear secretion | EYE RESEARCH INSTITUTE OF RETINA FOUNDATION (US) | 1987-09-02 | — | — | EP | claimed |
| WO-1987001586-A1 | AEROSOL | BIOCOMPATIBLES LIMITED (GB) | 1987-03-26 | — | — | WO | claimed |
| EP-0213083-A2 | Controlled release tablet | Zyma SA (CH) | 1987-03-04 | — | — | EP | claimed |
| US-4568676-A | SYNERGISTIC INHIBITION | THOMAS JEFFERSON UNIVERSITY (US) | 1986-02-04 | — | — | US | claimed |
| US-4562194-A | BENZOPHENONE COMPOUND IN COMBINATION WITH 3-ISOBUTYL-1-METHYLANTHINE | WARNER-LAMBERT COMPANY (US) | 1985-12-31 | — | — | US | claimed |
| US-4390532-A | MUCOPOLYSACCHARIDES, SHIN DISORDERS | DR. CARL HAHN, G.M.B.H. (DE) | 1983-06-28 | — | — | US | claimed |
| US-4364922-A | ATRIOVENTRICULAR CONDUCTION BLOCK | UNIVERSITY OF VIRGINIA ALUMNI PATENTS FOUNDATION (US) | 1982-12-21 | — | — | US | claimed |
| US-4273774-A | 1,3-DIMETHYL-5-AMINOADMANTANE TOGETHER WITH CAFFEINE OR THEOPHYLLINE | MERZ & CO. (DE) | 1981-06-16 | — | — | US | claimed |